Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award Posted on 29/08/202429/08/2024 by ScienceFather Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine. Profile Scopus Profile ORCID Profile Education Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences. Professional Experience Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology. Research Interest Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science. Research Skills Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care. Award and Recognition Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research. Conclusion Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award. Publication Top Notes Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine. Profile Scopus Profile ORCID Profile Education Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences. Professional Experience Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology. Research Interest Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science. Research Skills Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care. Award and Recognition Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research. Conclusion Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award. Publication Top Notes Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology. Research Interest Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science. Research Skills Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care. Award and Recognition Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research. Conclusion Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award. Publication Top Notes Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award Posted on 27/08/202427/08/2024 by ScienceFather Dr. Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award Senior Researcher of Novosibirsk state university, Russia. Elena Prokopyeva is a distinguished researcher and educator based at the Federal Research Center of Fundamental and Translational Medicine in Novosibirsk, Russia. Her academic journey began at Novosibirsk State University and progressed through advanced research positions at institutions like the FBRI State Research Center of Virology and Biotechnology ‘Vector’. Dr. Prokopyeva holds a PhD focused on the phenotypic and genotypic properties of influenza viruses and has made significant contributions to virology, studying various viruses including influenza, coronaviruses, and adenoviruses. Her expertise extends to virological methods, immunohistochemistry, and serological diagnostics. Dr. Prokopyeva has authored numerous high-impact publications, reflecting her extensive research in infectious diseases and cell biology. She is also a reviewer for MDPI and an expert for the Russian Science Foundation. Her achievements, coupled with her teaching roles in embryology and histology, underscore her valuable contributions to the scientific community. Profile Scopus Profile ORCID Profile Education Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013. Professional Experience Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community. Research Interest Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research. Research Skills Elena Prokopyeva possesses a diverse and advanced skill set in research, particularly within virology and infectious diseases. Her expertise includes virological methods such as virus isolation, infection assays, and the determination of virus susceptibility to inhibitors. She is adept in immunofluorescence and immunohistochemistry techniques, essential for studying viral interactions and pathogenesis. Prokopyeva’s proficiency extends to serological diagnostics using hemagglutination and microneutralization assays, as well as molecular techniques like RNA/DNA isolation, real-time PCR, and gel electrophoresis. Her experience with light and electron microscopy further enhances her capability to analyze viral structures and disease mechanisms. Prokopyeva’s role as a reviewer and expert for scientific foundations highlights her strong analytical skills and contributions to advancing the field of virology. Her comprehensive research skills, combined with her active participation in professional organizations, underscore her significant impact and ongoing commitment to her field. Awards and Recognition Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award. Conclusion Elena Prokopyeva is a strong candidate for the Best Researcher Award due to her extensive research expertise, impressive publication record, and significant contributions to the field of virology. Her work in understanding and combating viral diseases, coupled with her role in educating future scientists, underscores her value as a researcher. Addressing the areas for improvement could further enhance her standing and impact in the scientific community. Overall, Prokopyeva’s achievements and ongoing contributions make her a worthy candidate for the award. Publications Top Notes “Genetic Diversity of the Human Adenovirus C Isolated from Hospitalized Children in Russia (2019–2022)” Authors: Kurskaya, O.G., Prokopyeva, E.A., Dubovitskiy, N.A., Shestopalov, A.M., Sharshov, K.A. Journal: Viruses Year: 2024 Volume: 16(3) Article Number: 386 Citations: 1 “Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation” Authors: Mazin, M.E., Perevalova, A.M., Yarushkin, A.A., Gulyaeva, L.F., Pustylnyak, V.O. Journal: Biochemistry (Moscow) Year: 2023 Volume: 88(8) Pages: 1061–1069 “Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus” Authors: Kurskaya, O.G., Prokopyeva, E.A., Sobolev, I.A., Shestopalov, A.M., Sharshov, K.A. Journal: Viruses Year: 2023 Volume: 15(4) Article Number: 934 Citations: 8 “Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia” Authors: Dubovitskiy, N., Derko, A., Sobolev, I., Shestopalov, A., Sharshov, K. Journal: Viruses Year: 2023 Volume: 15(3) Article Number: 734 Citations: 1 “Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018” Authors: Prokopyeva, E.A., Kurskaya, O.G., Solomatina, M.V., Shestopalov, A.M., Sharshov, K.A. Journal: Journal of Infection in Developing Countries Year: 2023 Volume: 17(2) Pages: 251–259 Citations: 2 “Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation” Authors: Mazin, M.E., Yarushkin, A.A., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O. Journal: Molecular Biology Reports Year: 2022 Volume: 49(5) Pages: 4089–4093 Citations: 2 “Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013–2020)” Authors: Kurskaya, O.G., Prokopyeva, E.A., Anoshina, A.V., Shestopalov, A.M., Sharshov, K.A. Journal: Journal of Microbiology, Immunology and Infection Year: 2022 Volume: 55(2) Pages: 336–340 Citations: 3 “Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau” Authors: Kurskaya, O., Prokopyeva, E., Bi, H., Wei, L., Sharshov, K. Journal: Viruses Year: 2022 Volume: 14(2) Article Number: 360 Citations: 7 “Etiology of influenza-like illnesses in the population of Novosibirsk City in the 2018-2019 epidemic season” Authors: Kurskaya, O.G., Anoshina, A.V., Leonova, N.V., Shestopalov, A.M., Sharshov, K.A. Journal: Russian Journal of Infection and Immunity Year: 2021 Volume: 11(4) Pages: 723–736 Citations: 2 “Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation” Authors: Yarushkin, A.A., Mazin, M.E., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O. Journal: European Journal of Pharmacology Year: 2020 Volume: 879 Article Number: 173135 Citations: 6
Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013.
Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community.
Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.
Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.
Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award. Conclusion
Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award Posted on 23/08/202423/08/2024 by ScienceFather Assoc Prof Dr. Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award Supervisor of Islamic Azad University, Iran. Dr. Fahimeh Alizadeh is an accomplished researcher and educator in the field of microbial biotechnology, currently serving as an Associate Professor at the Department of Biology, Islamic Azad University, Gachsaran, Iran. With over two decades of experience in academia, she has previously held roles at the Yasooj Branch of Islamic Azad University, including positions as Head of the Department of Biology and Paramedical Sciences. Dr. Alizadeh’s research expertise encompasses microbial interactions, nanoparticle applications, and antifungal and antibacterial agents. Her significant contributions include research on the molecular mechanisms of Candida species, nanoparticle-based therapies, and biofilm formation. She has secured notable research grants and published extensively in high-impact journals. Dr. Alizadeh holds a Ph.D. from the University of Putra Malaysia and a Post-Doctoral fellowship from the same institution. Her extensive publication record and leadership in scientific research underscore her prominent role in her field. Profile Scopus Profile ORCID Profile Education Fahimeh Alizadeh holds a robust academic background in microbiology and microbial biotechnology. She completed her Bachelor’s and Master’s degrees in Biology-Microbiology at Islamic Azad University, Iran, where she laid the foundation for her specialization. She further advanced her expertise by earning a Ph.D. in Microbial Biotechnology from the University of Putra Malaysia, Malaysia, where she delved into advanced research techniques and microbial interactions. Dr. Alizadeh continued her scholarly journey with a post-doctoral fellowship at the same institution, focusing on cutting-edge microbial biotechnology. Her educational trajectory reflects a strong commitment to understanding microbial systems and advancing biotechnological applications, equipping her with comprehensive knowledge and research capabilities in her field. Professional Experience Dr. Fahimeh Alizadeh has an extensive academic and research career, currently serving as an Associate Professor in the Department of Biology at Gachsaran Branch, Islamic Azad University, Iran since 2023. Prior to this role, she was an Assistant Professor at Yasooj Branch, Islamic Azad University from 2000 to 2023, where she also held leadership positions as Head of the Department of Biology and Head of the Department of Paramedical Sciences at different intervals. Her teaching expertise spans across various subjects, including Biology, Medical Biochemistry, Immunology, and Microbiology. Dr. Alizadeh’s research experience is highlighted by her involvement in several significant projects and grants, including studies on microbial interactions, nanoparticles, and antifungal activities. Her contributions to the field are reflected in her numerous journal publications and research grants, underscoring her commitment to advancing scientific knowledge in microbial biotechnology and related disciplines. Research Interest Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents. Research Skills Dr. Fahimeh Alizadeh demonstrates exceptional research skills in the field of microbiology and microbial biotechnology. Her expertise encompasses a broad range of techniques and methodologies, including the isolation and characterization of transcription factors, the development of nanoparticles for therapeutic applications, and the study of antifungal and antibacterial properties of natural compounds. Dr. Alizadeh excels in molecular profiling and transcriptomic analysis, employing massive parallel sequencing to investigate gene expression during pathogen interactions. Her research frequently involves complex in vitro and in vivo studies, such as evaluating the inhibitory effects of various compounds on pathogenic microorganisms and cancer cell lines. Her ability to synthesize and analyze data from diverse experimental approaches highlights her proficiency in translating fundamental research into practical applications. This comprehensive skill set underscores her significant contributions to advancing knowledge in microbial biotechnology and therapeutic development. Awards and Recognition Dr. Fahimeh Alizadeh has garnered notable recognition for her impactful contributions to microbial biotechnology and her extensive research in the field. She has been acknowledged for her groundbreaking work on the molecular mechanisms of antifungal agents and nanoparticles in combating resistant pathogens. Her research projects, such as the study on thymol- and carvacrol-loaded nanoparticles and Candida species, have significantly advanced the understanding of antifungal resistance mechanisms. Dr. Alizadeh’s publications in prominent journals, including Pharmaceutical Sciences and Applied Biochemistry and Biotechnology, highlight her expertise and commitment to advancing medical and environmental microbiology. Her leadership roles as Head of the Department of Biology at Yasooj Branch and her active involvement in international research projects further demonstrate her excellence in academia. These achievements underscore her significant contributions to science and her esteemed position in the research community. Conclusion Fahimeh Alizadeh is a highly qualified candidate for the Research for Best Researcher Award, with extensive experience in academia, significant research contributions, and a strong publication record. Her leadership roles and research projects highlight her expertise and commitment to advancing microbial biotechnology. Publications Top Notes Anti-cancer activity of secreted aspartyl proteinase protein from Candida tropicalis on human cervical cancer HeLa cells Authors: E.P. Kokhdan, P. Khodavandi, M.H. Ataeyan, A. Khodavandi, A. Zaheri Year: 2024 Possible Molecular Targeting of Biofilm-Associated Genes by Nano-Ag in Candida albicans Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador Year: 2024 Possibility of intrauterine transmission from mother to fetus/newborn: Systematic review and meta-analysis of diagnostic methods to detect SARS-CoV-2 infection Authors: P. Khodavandi, A. Khodavandi, F. Alizadeh, L. Gholizadeh Year: 2024 Citations: 1 Hyphae-specific genes: Possible molecular targets for magnetic iron oxide nanoparticles alone and combined with visible light in Candida albicans Authors: P. Khodavandi, A. Hosseini, A. Khodavandi, A. Azizi, M. Gerami Year: 2023 Citations: 1 Antibacterial and Anti-Biofilm Activities of Microbial Synthesized Silver and Magnetic Iron Oxide Nanoparticles Against Pseudomonas aeruginosa Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador Year: 2023 Citations: 3 Biofilm-associated genes as potential molecular targets of nano-Fe3O4 in Candida albicans Authors: M. Baghiat Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador Year: 2023 Citations: 1 Synergistic interaction of fluconazole/ sodium bicarbonate on the inhibition of Candida glabrata phospholipase gene Authors: S.M.K. Hosseini, F. Alizadeh, S. Nouripour-Sisakht, A. Khodavandi Year: 2022 Resistance profiling of metallo-betalactamase genes in clinical isolates of Enterobacteriaceae: Emergence of multidrug resistance Authors: H. Alizadeh, A. Khodavandi, F. Alizadeh, N. Bahador Year: 2021 Citations: 2 Antifungal activity of menthol alone and in combination on growth inhibition and biofilm formation of Candida albicans Authors: N. Norouzi, F. Alizadeh, A. Khodavandi, M. Jahangiri Year: 2021 Citations: 15 Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis Authors: A. Khodavandi, F. Alizadeh, A.F.A. Razis Year: 2021 Citations: 28
Fahimeh Alizadeh holds a robust academic background in microbiology and microbial biotechnology. She completed her Bachelor’s and Master’s degrees in Biology-Microbiology at Islamic Azad University, Iran, where she laid the foundation for her specialization. She further advanced her expertise by earning a Ph.D. in Microbial Biotechnology from the University of Putra Malaysia, Malaysia, where she delved into advanced research techniques and microbial interactions. Dr. Alizadeh continued her scholarly journey with a post-doctoral fellowship at the same institution, focusing on cutting-edge microbial biotechnology. Her educational trajectory reflects a strong commitment to understanding microbial systems and advancing biotechnological applications, equipping her with comprehensive knowledge and research capabilities in her field.
Dr. Fahimeh Alizadeh has an extensive academic and research career, currently serving as an Associate Professor in the Department of Biology at Gachsaran Branch, Islamic Azad University, Iran since 2023. Prior to this role, she was an Assistant Professor at Yasooj Branch, Islamic Azad University from 2000 to 2023, where she also held leadership positions as Head of the Department of Biology and Head of the Department of Paramedical Sciences at different intervals. Her teaching expertise spans across various subjects, including Biology, Medical Biochemistry, Immunology, and Microbiology. Dr. Alizadeh’s research experience is highlighted by her involvement in several significant projects and grants, including studies on microbial interactions, nanoparticles, and antifungal activities. Her contributions to the field are reflected in her numerous journal publications and research grants, underscoring her commitment to advancing scientific knowledge in microbial biotechnology and related disciplines.
Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents.
Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents.
Teymoor Ghanbari | Nanogenerators | Best Researcher Award Posted on 16/08/202416/08/2024 by ScienceFather Prof. Teymoor Ghanbari | Nanogenerators | Best Researcher Award Faculty Member at Shiraz University , Iran. Prof. Teymoor Ghanbari is a distinguished Full Professor at Shiraz University, renowned for his extensive contributions to electrical engineering. His research focuses on the design, modeling, and fabrication of electrical systems, including innovative hysteresis motors and fault current limiters. Prof. Ghanbari’s work has had significant geographic impact, improving power systems and energy efficiency both within Iran and internationally. He has published over 100 journal papers, more than 50 conference papers, and holds six patents, reflecting his prolific output and influence. His awards include being ranked among the top 1% of scientists globally by WOS and ESI, and he has been recognized as an outstanding professor in research multiple times. Prof. Ghanbari’s expertise extends to applied research in power system management, with practical projects enhancing reliability and safety. His notable achievements and global recognition highlight his exceptional contributions to the field of electrical engineering. Profile Scopus Profile Education Prof. Teymoor Ghanbari’s educational journey reflects his deep commitment to electrical engineering. He earned his PhD in Electrical Engineering from Shiraz University in October 2012. His doctoral dissertation, titled “Initial Management of Transients in Microgrids, Challenges and Strategies,” was supervised by Prof. Ebrahim Farjah, Dr. Haidar Samet, Prof. Mahmud Fotoohi, and Dr. Mohammad Mohammadi. Prior to his PhD, Prof. Ghanbari completed his Master’s degree at Shahrood University of Technology in October 2007, where he focused on the “Analysis of Dynamic Behaviors of Hysteresis Motor Using a Suitable Model,” under the guidance of Prof. Ahmad Darabi. His academic foundation began with a Bachelor’s degree in Electrical Engineering from Sh. Rajaee University, completed in May 1997. This rigorous educational background has laid the groundwork for his innovative contributions to the field of electrical engineering. Professional Experience Prof. Teymoor Ghanbari, a Full Professor at Shiraz University, has a distinguished career in electrical engineering, marked by significant contributions to power systems and electrical motor technology. His professional journey began with the invention of several types of hysteresis motors and the development of fault current limiters for AC and DC power systems. He has led projects on power systems components monitoring, transient limiters, and energy efficiency improvements. Notable achievements include designing a battery management system for SOHA satellite and assessing fault ride-through capabilities for PV farms. Prof. Ghanbari’s leadership extends to academic and conference roles, including serving as a scientific chair at major international conferences. His expertise is recognized globally, with multiple awards and a strong publication record, underscoring his impact on both theoretical and applied aspects of electrical engineering. Research Interest Prof. Teymoor Ghanbari’s research interests are primarily centered around electrical engineering, focusing on the modeling, design, and fabrication of electrical systems and components. His work encompasses a wide range of areas, including the invention of various hysteresis motors and the development of fault current limiters for both AC and DC power systems. Prof. Ghanbari’s research also delves into power system monitoring, failure detection, and the implementation of advanced protection approaches for electric motors, transformers, and converters. His innovative projects include designing transient limiters, developing battery management systems, and assessing the fault ride-through capabilities of large-scale photovoltaic farms. With a strong emphasis on practical applications and real-world problem-solving, Prof. Ghanbari’s research aims to enhance the reliability, efficiency, and safety of electrical systems and power management technologies. Research Skills Prof. Teymoor Ghanbari exhibits exceptional research skills in the field of electrical engineering, showcasing a profound expertise in modeling, design, and fabrication of advanced electrical systems. His skills include the development of innovative hysteresis motors and fault current limiters, demonstrating a strong grasp of complex engineering principles and applications. Prof. Ghanbari excels in applied research, with a notable ability to translate theoretical concepts into practical solutions for power systems management and fault detection. His proficiency extends to designing transient limiters and monitoring systems, reflecting his capability in addressing real-world challenges in energy efficiency and system reliability. Additionally, his extensive publication record and patent portfolio highlight his ability to conduct rigorous research and contribute valuable knowledge to the field. Prof. Ghanbari’s skills are further evidenced by his leadership roles in academic conferences and his mentorship of graduate students, underscoring his commitment to advancing research and fostering innovation. Parasitology and Infectious Diseases Prof. Ghanbari’s research does not focus on parasitology or infectious diseases. His expertise is centered around electrical engineering and power systems, with no direct contributions to these fields. Awards and Recognition Prof. Ghanbari has received several prestigious awards and recognitions, including being ranked among the top 1% of scientists globally by WOS and ESI. He has also been recognized as an outstanding professor in research at Shiraz University and Fars province. His inclusion in the World’s Top 2% Scientists List by Stanford University and Elsevier further highlights his significant impact in his field. Conclusion Prof. Teymoor Ghanbari’s extensive research contributions, applied innovations, and global impact make him a strong candidate for the Best Researcher Award. His work in electrical engineering, particularly in developing advanced power system technologies and fault detection methods, demonstrates his leadership and dedication to advancing the field. His numerous awards and recognitions underscore his exceptional achievements and contributions to the scientific community. Publications Top Notes Fault ride through enhancement of large-scale solar plants using distributed converters Authors: S.M.H. Mousavi, T. Ghanbari, E. Farjah, A. Mehraban Year: 2024 Stator winding fault detection of induction motors using fast Fourier transform on rotor slot harmonics and least square analysis of the Park’s vectors Authors: T. Ghanbari, A. Mehraban Year: 2024 AI-Based Control of Storage Capacity in High-Power-Density Energy Storage Systems, Used in Electric Vehicles Authors: A. Mehraban, T. Ghanbari, E. Farjah Year: 2024 Citations: 5 Adaptation of Triboelectric Nanogenerators to the Integrated Energy Storages by a Textured Multi-Segment Structure Authors: N. Sharif, T. Ghanbari, Z. Hosseini, K. Shahbazi, A. Mehraban Year: 2024 Integrated Optimal Energy Management and Sizing of Hybrid Battery/Flywheel Energy Storage for Electric Vehicles Authors: A. Mehraban, E. Farjah, T. Ghanbari, L. Garbuio Year: 2023 Citations: 4 Application of a Rogowski Coil Sensor for Separating Internal and External Partial Discharge Pulses in Power Transformers Authors: S. Sharifinia, M. Allahbakhshi, T. Ghanbari, H. Pakniat Year: 2023 Citations: 2 Fault Detection in DC Microgrid: A Transient Monitoring Function-Based Method Authors: M.A. Jarrahi, H. Samet, T. Ghanbari Year: 2023 Citations: 4 A Modular Unipolar/Bipolar High-Voltage Pulse Generator Suitable for High Resistive Load Authors: M. Taherian, S. Roshan, M. Allahbakhshi, E. Farjah, T. Ghanbari Year: 2023 Citations: 1 Dynamic Polynomial Models With ARMA Coefficients Used for Modeling the DC Series Arc Fault in Photovoltaic Systems Authors: M. Jalil, H. Samet, T. Ghanbari Year: 2023 Citations: 2 Partial shading detection and hotspot prediction in photovoltaic systems based on numerical differentiation and integration of the P − V curves Authors: M. Khodapanah, T. Ghanbari, E. Moshksar, Z. Hosseini Year: 2023 Citations: 9
Fault ride through enhancement of large-scale solar plants using distributed converters Authors: S.M.H. Mousavi, T. Ghanbari, E. Farjah, A. Mehraban Year: 2024 Stator winding fault detection of induction motors using fast Fourier transform on rotor slot harmonics and least square analysis of the Park’s vectors Authors: T. Ghanbari, A. Mehraban Year: 2024 AI-Based Control of Storage Capacity in High-Power-Density Energy Storage Systems, Used in Electric Vehicles Authors: A. Mehraban, T. Ghanbari, E. Farjah Year: 2024 Citations: 5 Adaptation of Triboelectric Nanogenerators to the Integrated Energy Storages by a Textured Multi-Segment Structure Authors: N. Sharif, T. Ghanbari, Z. Hosseini, K. Shahbazi, A. Mehraban Year: 2024 Integrated Optimal Energy Management and Sizing of Hybrid Battery/Flywheel Energy Storage for Electric Vehicles Authors: A. Mehraban, E. Farjah, T. Ghanbari, L. Garbuio Year: 2023 Citations: 4 Application of a Rogowski Coil Sensor for Separating Internal and External Partial Discharge Pulses in Power Transformers Authors: S. Sharifinia, M. Allahbakhshi, T. Ghanbari, H. Pakniat Year: 2023 Citations: 2 Fault Detection in DC Microgrid: A Transient Monitoring Function-Based Method Authors: M.A. Jarrahi, H. Samet, T. Ghanbari Year: 2023 Citations: 4 A Modular Unipolar/Bipolar High-Voltage Pulse Generator Suitable for High Resistive Load Authors: M. Taherian, S. Roshan, M. Allahbakhshi, E. Farjah, T. Ghanbari Year: 2023 Citations: 1 Dynamic Polynomial Models With ARMA Coefficients Used for Modeling the DC Series Arc Fault in Photovoltaic Systems Authors: M. Jalil, H. Samet, T. Ghanbari Year: 2023 Citations: 2 Partial shading detection and hotspot prediction in photovoltaic systems based on numerical differentiation and integration of the P − V curves Authors: M. Khodapanah, T. Ghanbari, E. Moshksar, Z. Hosseini Year: 2023 Citations: 9
Tsuksa Nabekura | Immunology and Microbiology | Best Researcher Award Posted on 16/08/202416/08/2024 by ScienceFather Prof. Tsukasa Nabekura | Immunology and Microbiology | Best Researcher Award Ph.D. at Aichi Cancer Center Research Institute , Japan. Dr. Tsukasa Nabekura is a prominent immunologist known for his groundbreaking research on natural killer (NK) cells. Since 2008, he has made significant contributions to understanding NK cell receptors and their roles in immune responses to viral infections, cancer, and tissue injury. His work has led to key insights into NK cell differentiation, function, and memory, as evidenced by his publications in high-impact journals like Immunity and Journal of Experimental Medicine. Dr. Nabekura’s research has global significance, with collaborations spanning institutions such as the University of California, San Francisco, and the University of Tsukuba, Japan. His achievements have been recognized with prestigious awards, including the Young Investigator Award from the Japanese Society of Immunology and the BEST FACULTY MEMBER award. Dr. Nabekura’s research continues to advance the field of immunology, with potential implications for therapeutic strategies in cancer and infectious diseases. Profile Scopus Profile Education Dr. Tsukasa Nabekura’s educational background reflects a strong foundation in biological and medical sciences. He completed his Bachelor of Science in Biology in March 2003, followed by a Master of Arts in Medical Science in March 2005, both from the University of Tsukuba, Japan. Dr. Nabekura then pursued a Ph.D. in Medicine at the same institution, graduating in March 2008. His commitment to advancing his expertise continued with postdoctoral research at the University of Tsukuba, where he focused on Immunology and completed his postdoc in October 2011. Further enhancing his qualifications, he undertook an additional postdoctoral fellowship at the University of California, San Francisco, from October 2014. This extensive educational journey equipped Dr. Nabekura with a deep understanding of immunology and cell biology, setting the stage for his influential research on natural killer (NK) cells and their roles in immune responses. Professional Experience Dr. Tsukasa Nabekura has built a distinguished career in immunology with a focus on natural killer (NK) cells. After completing his postdoctoral research in immunology at the University of California, San Francisco, he returned to Japan as an Assistant Professor in the Life Science Center of Tsukuba Advanced Research Alliance at the University of Tsukuba. His expertise led him to roles at the Life Science Center for Survival Dynamics and the Division of Immune Response at the Aichi Cancer Center Research Institute. Dr. Nabekura’s professional trajectory reflects a strong commitment to advancing immunological research and understanding NK cell biology. His career is marked by his significant contributions to the field through his research on NK cell function and memory, collaborative efforts with leading scientists, and the recognition he has received through various awards and honors. Research Interest Dr. Tsukasa Nabekura’s research interests center on the intricate roles of natural killer (NK) cells in immune responses. Since 2008, his work has delved into how NK receptors and associated molecules influence innate and adaptive immunity against viral infections, cancer, and acute tissue injury. His research has elucidated the pivotal role of DNAX accessory molecule-1 (DNAM-1) in NK cell memory differentiation and its impact on acute graft-versus-host disease. Dr. Nabekura has also investigated how activating receptors enhance NK cell functions and memory during infections. His recent studies focus on the regulatory functions of Themis2 in NK cell memory and antitumor activity. By exploring these aspects, Dr. Nabekura aims to advance our understanding of immune responses and contribute to the development of new therapeutic strategies for treating cancer and viral diseases. Research Skills Dr. Tsukasa Nabekura possesses a diverse range of advanced research skills that underscore his expertise in immunology. His proficiency in cellular and molecular immunology is evident from his extensive work on natural killer (NK) cells, including their receptors and associated molecules. He has demonstrated exceptional skills in experimental design and execution, particularly in studying NK cell function during viral infections and cancer. Dr. Nabekura’s expertise extends to cutting-edge techniques in cell biology, including flow cytometry, immunohistochemistry, and cytokine profiling. His ability to collaborate with leading researchers and institutions further highlights his strong skills in cross-disciplinary research and team-based science. Additionally, Dr. Nabekura’s experience in securing research fellowships and grants reflects his competence in research proposal development and project management. His comprehensive approach to studying immune responses and his successful publication record illustrate his high level of research acumen and dedication to advancing scientific knowledge. Awards and Recognition Dr. Nabekura has received numerous awards, including the Young Investigator Award from the Japanese Society of Immunology and the BEST FACULTY MEMBER award at the University of Tsukuba. These accolades reflect his outstanding contributions and recognition within the scientific community. Conclusion Dr. Tsukasa Nabekura’s exceptional research on NK cells and immune responses demonstrates his profound impact on the field of immunology. His contributions to understanding immune mechanisms, his collaborative efforts, and his recognition through various awards underscore his suitability for the Research for Best Researcher Award. His work continues to advance scientific knowledge and has the potential to influence therapeutic strategies for infectious diseases and cancer. Publications Top Notes THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling Authors: E.A. Deborah, T. Nabekura, K. Shibuya, A. Shibuya Year: 2024 Themis2 regulates natural killer cell memory function and formation Authors: T. Nabekura, E.A. Deborah, S. Tahara, M. Muratani, A. Shibuya Year: 2023 Citations: 4 DNAM-1 Immunoreceptor Protects Mice from Concanavalin A-Induced Acute Liver Injury by Reducing Neutrophil Infiltration Authors: S. Matsuo, T. Nabekura, K. Matsuda, K. Shibuya, A. Shibuya Year: 2023 Citations: 1 Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches Authors: T. Asahi, S. Abe, G. Cui, H. Ohno, K. Ikuta Year: 2023 Citations: 4 The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells Authors: O.A. Aguilar, M.D.R. Gonzalez-Hinojosa, J.S. Arakawa-Hoyt, T. Nabekura, L.L. Lanier Year: 2023 Citations: 8 Early reactivation of clustered genes on the inactive X chromosome during somatic cell reprogramming Authors: S. Aizawa, K. Nishimura, G.S. Mondejar, Y. Hayashi, K. Hisatake Year: 2022 Citations: 3 Erratum: Corrigendum to selective expression of a C-type lectin receptor, Clec12b, on skin mast cells Authors: A. Iijima, K. Kanemaru, Y. Wang, S. Tahara-Hanaoka, A. Shibuya Year: 2021 Selective expression of a C-type lectin receptor, Clec12b, on skin mast cells Authors: A. Iijima, K. Kanemaru, Y. Wang, S. Tahara-Hanaoka, A. Shibuya Year: 2021 Type 1 innate lymphoid cells: Soldiers at the front line of immunity Authors: T. Nabekura, A. Shibuya Year: 2021 Citations: 17 ILC1: guardians of the oral mucosa against enemy viruses Authors: T. Nabekura, A. Shibuya Year: 2021 Citations: 7